Over-the-counter medications in pregnancy

American Family Physician

Volumn 67, Issue 12, 2003, Pages 2517-2524

  Black, Ronald A ^a   Hill, D Ashley ^a,b  

^a FLORIDA HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALUMINUM MAGNESIUM HYDROXIDE; ANTACID AGENT; ANTIDIARRHEAL AGENT; ATROPINE PLUS DIPHENOXYLATE; BISMUTH SALICYLATE; BUTOCONAZOLE; CALCIUM CARBONATE; CHLORPHENIRAMINE; CHLORPHENIRAMINE MALEATE; CIMETIDINE; CLEMASTINE FUMARATE; CLOTRIMAZOLE; DECONGESTIVE AGENT; DEXTROMETHORPHAN; DIETHYLSTILBESTROL; DIPHENHYDRAMINE; EXPECTORANT AGENT; FAMOTIDINE; FLUCONAZOLE; FLUCYTOSINE; GRISEOFULVIN; GUAIFENESIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HUMIBID; IBUPROFEN; KAOLIN; KAOLIN PECTIN; KETOCONAZOLE; KETOPROFEN; LOPERAMIDE; MICONAZOLE; MYLANTA GAS; NAPROXEN; NICOTINE; NIZATIDINE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; NYSTATIN; PARACETAMOL; PECTIN; PSEUDOEPHEDRINE; RANITIDINE; SIMETHICONE; TERCONAZOLE; THALIDOMIDE; TIOCONAZOLE; TUMS; UNINDEXED DRUG;

ARTICLE; BIRTH DEFECT; BRAIN HEMORRHAGE; DRUG SAFETY; DRUG USE; FETOTOXICITY; FOOD AND DRUG ADMINISTRATION; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; NEONATAL HEMORRHAGE; NEPHROTOXICITY; NEURAL TUBE DEFECT; OLIGOHYDRAMNIOS; PERINATAL MORTALITY; POSTMATURITY; PREGNANCY; PRENATAL DRUG EXPOSURE; PULMONARY HYPERTENSION; RISK BENEFIT ANALYSIS; SMOKING CESSATION; TERATOGENICITY;

DRUGS, NON-PRESCRIPTION; FEMALE; FETUS; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; RISK FACTORS;

EID: 0038374993     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jacobs LR. Prescription to over-the-counter drug reclassification. Am Fam Physician 1998;57:2209-14.
2. Matt DW, Borzelleca JF. Toxic effects on the female reproductive system during pregnancy, parturition, and lactation. In: Witorsch RJ, ed. Reproductive toxicology. 2d ed. New York: Raven, 1995:175-93.
3. Wilson JG. Current status of teratology. In: Wilson JG, Fraser FC, eds. Handbook of teratology. New York: Plenum, 1977:47.
4. Briggs GG, Freeman RK, Yaffe SJ, eds. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins, 1998:577-8,627-8.
5. Collins E. Maternal and fetal effects of acetaminophen and salicylates in pregnancy. Obstet Gynecol 1981;58(5 Suppl):57S-62S.
6. Macones GA, Marder SJ, Clothier B, Stamilio DM. The controversy surrounding indomethacin for tocolysis. Am J Obstet Gynecol 2001;184:264-72.
7. Hauth JC, Goldenberg RL, Parker CR Jr, Cutter GR, Cliver SP. Low-dose aspirin: lack of association with an increase in abruptio placentae or perinatal mortality. Obstet Gynecol 1995;85:1055-8.
8. Barry WS, Meinzinger MM, Howse CR. Ibuprofen overdose and exposure in utero: results from a postmarketing voluntary reporting system. Am J Med 1984;77:35-9.
9. Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology 1992;45:361-7.
10. The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and the American College of Allergy, Asthma, and Immunology (ACAAI). Ann Allergy Asthma Immunol 2000;84: 475-80.
11. Smith CV, Rayburn WF, Anderson JC, Duckworth AF, Appel LL. Effect of a single dose of oral pseudoephedrine on uterine and fetal Doppler blood flow. Obstet Gynecol 1990;76(5 Pt 1):803-6.
12. Brost BC, Scardo JA, Newman RB. Diphenhydramine overdose during pregnancy: lessons from the past. Am J Obstet Gynecol 1996;175:1376-7.
13. Kargas GA, Kargas SA, Bruyere HJ Jr, Gilbert EF, Opitz JM. Perinatal mortality due to interaction of diphenhydramine and temazepam. N Engl J Med 1985;313:1417-8.
14. Einarson A, Lyszkiewicz D, Koren G. The safety of dextromethorphan in pregnancy: results of a controlled study. Chest 2001;119:466-9.
15. Aselton P, Jick H, Milunsky A, Hunter JR, Stergachis A. First-trimester drug use and congenital disorders. Obstet Gynecol 1985;65:451-5.
16. Shaw GM, Todoroff K, Velie EM, Lammer EJ. Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology 1998;57:1-7.
17. Patterson EC, Staszak DJ. Effects of geophagia (kaolin ingestion) on the maternal blood and embryonic development in the pregnant rat. J Nutr 1977;107:2020.
18. Bonapace ES Jr, Fisher RS. Constipation and diarrhea in pregnancy. Gastroenterol Clin North Am 1998;27:197-211.
19. Gilbert-Barness E, Barness LA, Wolff J, Harding C. Aluminum toxicity. Arch Pediatr Adolesc Med 1998;152:511-2.
20. Larson JD, Patatanian E, Miner PB Jr, Rayburn WF, Robinson MG. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynecol 1997;90:83-7.
21. 2-receptor antagonists by the human and baboon placenta. Am J Med Sci 1988;295:198-206.
22. Katz PO, Castell DO. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 1998;27:153-67.
23. Lagace E. Safety of first trimester exposure to H2 blockers. J Fam Pract 1996;43:342-3.
24. Czeizel AE, Toth M, Rockenbauer M. No teratogenic effect after clotrimazole therapy during pregnancy. Epidemiology 1999;10:437-40.
25. Mastroiacovo P, Mazzone T, Botto LD, Serafini MA, Finardi A, Caramelli L, et al. Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. Am J Obstet Gynecol 1996; 175:1645-50.
26. King CT, Rogers PD, Cleary JD, Chapman SW. Antifungal therapy during pregnancy. Clin Infect Dis 1998;27:1151-60.
27. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Recomm Rep 1998;47(RR-1):1-111.
28. Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database Syst Rev 2001;CD000225.
29. DiFranza JR, Lew RA. Effect of maternal cigarette smoking on pregnancy complications and sudden infant death syndrome. J Fam Pract 1995;40:385-94.
30. Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf 2001;24:277-322.